LIVN insider transaction filings
LivaNova PLC — 45 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-13. Screen LIVN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | Tezel Ahmet — Chief Innovation Officer | Option exercise (M): 12,692 @ $52.68 · Disposition to issuer (D): 8,589 @ $77.86 · Tax withholding (F): 1,428 @ $77.86 · Sale (S): 2,675 @ $77.74 · Option exercise (M): 12,692 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Bianchi Francesco — Director | Option exercise (M): 4,042 @ $0 · Tax withholding (F): 486 @ $79.70 · Sale (S): 1,200 @ $80.19 · Option exercise (M): 4,042 (derivative) @ $0 · Grant/award (A): 2,383 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | PODLOGAR SUSAN M — Director | Option exercise (M): 4,042 @ $0 · Tax withholding (F): 486 @ $79.70 · Option exercise (M): 4,042 (derivative) @ $0 · Grant/award (A): 2,383 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Barry James Christopher — Director | Option exercise (M): 4,042 @ $0 · Tax withholding (F): 486 @ $79.70 · Option exercise (M): 4,042 (derivative) @ $0 · Grant/award (A): 2,383 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Tezel Ahmet — Chief Innovation Officer | Option exercise (M): 2,965 @ $0 · Tax withholding (F): 1,032 @ $79.70 · Option exercise (M): 2,965 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Nygaard-Andersen Jette — Director | Grant/award (A): 2,383 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Story Brooke — Director | Option exercise (M): 4,042 @ $0 · Tax withholding (F): 486 @ $79.70 · Option exercise (M): 4,042 (derivative) @ $0 · Grant/award (A): 2,383 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Zurbay Donald — Director | Option exercise (M): 2,560 @ $0 · Tax withholding (F): 308 @ $79.70 · Option exercise (M): 2,560 (derivative) @ $0 · Grant/award (A): 2,383 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Enxing Seng Stacy — Director | Option exercise (M): 4,042 @ $0 · Tax withholding (F): 486 @ $79.70 · Option exercise (M): 4,042 (derivative) @ $0 · Grant/award (A): 2,383 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | WILVER PETER M — Director | Option exercise (M): 4,042 @ $0 · Tax withholding (F): 486 @ $79.70 · Option exercise (M): 4,042 (derivative) @ $0 · Grant/award (A): 2,383 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | KOZY WILLIAM A — Director | Option exercise (M): 5,681 @ $0 · Tax withholding (F): 682 @ $79.70 · Option exercise (M): 5,681 (derivative) @ $0 · Grant/award (A): 2,383 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | SCHERMERHORN TODD C — Director | Option exercise (M): 4,042 @ $0 · Tax withholding (F): 486 @ $79.70 · Option exercise (M): 4,042 (derivative) @ $0 · Grant/award (A): 2,383 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | Bianchi Francesco — Director | Sale (S): 1,800 @ $75.75 | EDGAR |
| 2026-04-01 | 4 | Tezel Ahmet — Chief Innovation Officer | Option exercise (M): 3,408 @ $0 · Tax withholding (F): 1,186 @ $61.27 · Option exercise (M): 3,408 (derivative) @ $0 · Grant/award (A): 13,873 (derivative) @ $0 · Grant/award (A): 4,624 (derivative) @ $0 · Grant/award (A): 4,624 (derivative) @ $0 · +1 more | EDGAR |
| 2026-04-01 | 4 | Poletti Franco — President, Cardiopulmonary | Option exercise (M): 3,184 @ $0 · Tax withholding (F): 1,370 @ $61.27 · Option exercise (M): 171 (derivative) @ $0 · Option exercise (M): 325 (derivative) @ $0 · Option exercise (M): 558 (derivative) @ $0 · Option exercise (M): 2,130 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Shvartsburg Alex — Chief Financial Officer | Option exercise (M): 30,835 @ $0 · Tax withholding (F): 12,868 @ $61.27 · Option exercise (M): 914 (derivative) @ $0 · Option exercise (M): 2,364 (derivative) @ $0 · Option exercise (M): 1,787 (derivative) @ $0 · Option exercise (M): 3,621 (derivative) @ $0 · +7 more | EDGAR |
| 2026-04-01 | 4 | Makatsaria Vladimir — Chief Executive Officer, Director | Option exercise (M): 21,042 @ $0 · Tax withholding (F): 11,159 @ $61.27 · Option exercise (M): 3,352 (derivative) @ $0 · Option exercise (M): 5,977 (derivative) @ $0 · Option exercise (M): 11,713 (derivative) @ $0 · Grant/award (A): 52,227 (derivative) @ $0 · +3 more | EDGAR |
| 2026-04-01 | 4 | Bolton Stephanie — President, Global Epilepsy | Option exercise (M): 17,815 @ $0 · Tax withholding (F): 8,377 @ $61.27 · Option exercise (M): 457 (derivative) @ $0 · Option exercise (M): 1,330 (derivative) @ $0 · Option exercise (M): 1,229 (derivative) @ $0 · Option exercise (M): 2,343 (derivative) @ $0 · +7 more | EDGAR |
| 2026-04-01 | 4 | Kozmina Natalia — Chief Human Resources Officer | Option exercise (M): 6,389 @ $0 · Tax withholding (F): 1,374 @ $61.27 · Option exercise (M): 4,259 (derivative) @ $0 · Option exercise (M): 2,130 (derivative) @ $0 · Grant/award (A): 9,792 (derivative) @ $0 · Grant/award (A): 3,264 (derivative) @ $0 · +2 more | EDGAR |
| 2026-03-13 | 4 | Poletti Franco — President, Cardiopulmonary | Option exercise (M): 2,140 @ $57.60 · Tax withholding (F): 1,980 @ $62.26 · Tax withholding (F): 69 @ $62.26 · Option exercise (M): 2,140 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Poletti Franco — President, Cardiopulmonary | Option exercise (M): 967 @ $0 · Tax withholding (F): 416 @ $63.06 · Option exercise (M): 967 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | PODLOGAR SUSAN M — Director | Option exercise (M): 2,355 @ $0 · Tax withholding (F): 269 @ $63.06 · Option exercise (M): 2,355 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Hutchinson Michael Damon — SVP, CLO and Company Secretary | Option exercise (M): 2,254 @ $0 · Tax withholding (F): 1,122 @ $63.06 · Option exercise (M): 2,254 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Story Brooke — Director | Sale (S): 250 @ $53.94 | EDGAR |
| 2025-09-17 | 4 | Poletti Franco — President, Cardiopulmonary | Option exercise (M): 643 @ $0 · Tax withholding (F): 277 @ $55.43 · Option exercise (M): 643 (derivative) @ $0 | EDGAR |
| 2025-09-17 | 4 | Zurbay Donald — Director | Grant/award (A): 2,560 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | Bianchi Francesco — Director | Sale (S): 1,500 @ $56.50 | EDGAR |
| 2025-06-17 | 4 | O'Kane Sharon — Director | Option exercise (M): 3,416 @ $0 · Tax withholding (F): 1,606 @ $45.76 · Option exercise (M): 3,416 (derivative) @ $0 · Grant/award (A): 4,042 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Bianchi Francesco — Director | Option exercise (M): 3,416 @ $0 · Tax withholding (F): 410 @ $45.76 · Option exercise (M): 3,416 (derivative) @ $0 · Grant/award (A): 4,042 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Barry James Christopher — Director | Option exercise (M): 3,416 @ $0 · Tax withholding (F): 410 @ $45.76 · Option exercise (M): 3,416 (derivative) @ $0 · Grant/award (A): 4,042 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Story Brooke — Director | Option exercise (M): 3,416 @ $0 · Tax withholding (F): 410 @ $45.76 · Option exercise (M): 3,416 (derivative) @ $0 · Grant/award (A): 4,042 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Tezel Ahmet — Chief Innovation Officer | Option exercise (M): 2,967 @ $0 · Tax withholding (F): 1,032 @ $45.76 · Option exercise (M): 2,967 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | PODLOGAR SUSAN M — Director | Grant/award (A): 4,042 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Enxing Seng Stacy — Director | Option exercise (M): 3,416 @ $0 · Tax withholding (F): 410 @ $45.76 · Option exercise (M): 3,416 (derivative) @ $0 · Grant/award (A): 4,042 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | WILVER PETER M — Director | Option exercise (M): 3,416 @ $0 · Tax withholding (F): 410 @ $45.76 · Option exercise (M): 3,416 (derivative) @ $0 · Grant/award (A): 4,042 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | KOZY WILLIAM A — Director | Option exercise (M): 4,840 @ $0 · Tax withholding (F): 581 @ $45.76 · Option exercise (M): 4,840 (derivative) @ $0 · Grant/award (A): 5,681 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | SCHERMERHORN TODD C — Director | Option exercise (M): 3,416 @ $0 · Tax withholding (F): 410 @ $45.76 · Option exercise (M): 3,416 (derivative) @ $0 · Grant/award (A): 4,042 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Tezel Ahmet — Chief Innovation Officer | Grant/award (A): 10,222 (derivative) @ $0 · Grant/award (A): 5,111 (derivative) @ $0 · Grant/award (A): 5,111 (derivative) @ $0 · Grant/award (A): 10,222 (derivative) @ $0 · Grant/award (A): 22,378 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Bolton Stephanie — President, Global Epilepsy | Option exercise (M): 6,024 @ $0 · Tax withholding (F): 2,835 @ $39.13 · Option exercise (M): 426 (derivative) @ $0 · Option exercise (M): 457 (derivative) @ $0 · Option exercise (M): 1,330 (derivative) @ $0 · Option exercise (M): 1,229 (derivative) @ $0 · +8 more | EDGAR |
| 2025-04-01 | 4 | Makatsaria Vladimir — Chief Executive Officer, Director | Option exercise (M): 9,330 @ $0 · Tax withholding (F): 5,046 @ $39.13 · Option exercise (M): 3,352 (derivative) @ $0 · Option exercise (M): 5,978 (derivative) @ $0 · Grant/award (A): 35,139 (derivative) @ $0 · Grant/award (A): 17,569 (derivative) @ $0 · +3 more | EDGAR |
| 2025-04-01 | 4 | Shvartsburg Alex — Chief Financial Officer | Option exercise (M): 11,083 @ $0 · Tax withholding (F): 3,516 @ $39.13 · Option exercise (M): 853 (derivative) @ $0 · Option exercise (M): 914 (derivative) @ $0 · Option exercise (M): 2,364 (derivative) @ $0 · Option exercise (M): 1,788 (derivative) @ $0 · +8 more | EDGAR |
| 2025-04-01 | 4 | Kozmina Natalia — Chief Human Resources Officer | Grant/award (A): 12,777 (derivative) @ $0 · Grant/award (A): 6,388 (derivative) @ $0 · Grant/award (A): 3,194 (derivative) @ $0 · Grant/award (A): 3,194 (derivative) @ $0 · Grant/award (A): 6,388 (derivative) @ $0 · Grant/award (A): 13,986 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Poletti Franco — President, Cardiopulmonary | Option exercise (M): 1,257 @ $0 · Tax withholding (F): 542 @ $39.13 · Option exercise (M): 201 (derivative) @ $0 · Option exercise (M): 172 (derivative) @ $0 · Option exercise (M): 325 (derivative) @ $0 · Option exercise (M): 559 (derivative) @ $0 · +5 more | EDGAR |
| 2025-04-01 | 4 | Hutchinson Michael Damon — Chief Legal Officer | Option exercise (M): 2,930 @ $0 · Tax withholding (F): 1,020 @ $39.13 · Option exercise (M): 1,477 (derivative) @ $0 · Option exercise (M): 1,453 (derivative) @ $0 · Grant/award (A): 8,944 (derivative) @ $0 · Grant/award (A): 4,472 (derivative) @ $0 · +3 more | EDGAR |
| 2025-04-01 | 4 | KOZY WILLIAM A — Director | Option exercise (M): 1,034 @ $0 · Tax withholding (F): 188 @ $39.13 · Option exercise (M): 1,034 (derivative) @ $0 | EDGAR |
Recent 8-K events — LivaNova PLC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-21 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=LIVN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →